Tolerx
closedNovel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€5—8m (Dealroom.co estimates Dec 2010.)
Cambridge Massachusetts (HQ)
Authorizing premium user...